SMAD7 and inflammatory bowel disease: In IBD patients, specific antisense oligonucleotides restore TGFβ signaling and inhibit cytokine production, meaning that SMAD7 blockade of TGFβ signaling maintains chronic production of proinflammatory cytokines [44].